Is there a therapeutic window with some antidepressants for analgesic response?
- 94 Downloads
Most antidepressants and anticonvulsants used in chronic pain syndromes have dose- and concentration-response curves developed for their application to treat psychiatric disorders. Because these are important clinical tools in medication management of psychiatric syndromes, it is reasonable to expect that utilizing concentration-effect relationships and known sources of pharmacokinetic variability for determining doses for analgesia may also improve treatment tolerability and outcomes. Efforts to identify dosing “therapeutic windows” or minimum “thresholds” for analgesic efficacy have provided useful guidance for initiating treatment, reducing toxicity, and assisting with decision making in the face of limited therapeutic response. This article reviews the strengths, limitations, and potential of therapeutic drug monitoring of antidepressants and anticonvulsants as analgesics for selected chronic pain syndromes.
KeywordsNeuropathic Pain Gabapentin Venlafaxine Pregabalin Desipramine
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 2.Max MB: Antidepressants as analgesics. In Pharmacological Approaches to the Treatment of Chronic Pain: New Concepts and Critical Issues (Progress in Pain Research and Management), vol 1. Edited by Fields HL, Liebeskind JC. Seattle: IASP Press; 1994:229–246.Google Scholar
- 10.Teter CJ, Kando JC, Wells BG, et al.: Depressive disorders. In Pharmacotherapy: A Pathophysiologic Approach, edn 7. Edited by Dipiro JT. New York: McGraw Hill; 2009:1123–1140.Google Scholar
- 22.Kajdasz DK, Iyengar S, Desaiah D, et al.: Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies. Clin Ther 2007, 29:2536–2546.PubMedCrossRefGoogle Scholar